Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Concurrent Fluorescence and Sonographically Guided Eradication of Gliomas and Metastases Enhancing Contrast Agent in Magnetic Resonance Imaging: a Randomised, Controlled Trial

NCT05474573 is registered in ClinicalTrials.gov with Sklifosovsky Institute of Emergency Care as lead sponsor.

NCT NCT05474573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05474573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Concurrent Fluorescence and Sonographically Guided Eradication of Gliomas and Metastases Enhancing Contrast Agent in Magnetic Resonance Imaging: a Randomised, Controlled Trial
Lead sponsor
Sklifosovsky Institute of Emergency Care
Phase
Not applicable
Overall status
Recruiting
Start date
September 1, 2022
Completion date
August 31, 2027
Enrollment
52 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioma, malignant, metastases to brain